Santa Clarita Post-Acute Care: Antibiotic Lapses, CA
NEWHALL, CA - Federal inspectors found Santa Clarita Post-acute Care Center failed to properly monitor a resident's long-term antibiotic use, potentially exposing the patient to unnecessary medication risks and antibiotic resistance.
Prolonged Antibiotic Use Without Proper Oversight
During a February 2025 inspection, surveyors discovered that a 37-year-old resident with cognitive impairment had been prescribed methenamine hippurate, an antibacterial medication, for urinary tract infection prevention since September 2023 without adequate monitoring protocols in place.
The resident, who was admitted in March 2023 with multiple medical conditions including thrombocytopenia (low platelet count), gastroesophageal reflux disease, and a history of stroke, had moderate cognitive impairment that affected their ability to make medical decisions. Despite being on this high-risk medication class for over a year, facility staff failed to implement proper monitoring procedures.
According to medical records reviewed during the inspection, the resident was prescribed methenamine hippurate 1 gram tablets twice daily for UTI prevention. However, the medication order contained no provisions for monitoring signs and symptoms of UTI, leaving staff without clear guidance on how to assess the drug's effectiveness or identify potential complications.
Medical Significance of Monitoring Requirements
Methenamine hippurate requires careful oversight due to its potential for adverse effects and the risk of developing antibiotic resistance. The medication works by releasing formaldehyde in acidic urine, which helps prevent bacterial growth in the urinary tract. However, prolonged use without proper monitoring can lead to several serious complications.
According to established medical protocols, patients taking methenamine hippurate should receive regular kidney function monitoring - at least annually for those without kidney problems and weekly to monthly for patients with compromised kidney function. The medication can cause side effects including skin rash, nausea, and vomiting, particularly with extended use.
Antibiotic stewardship principles require healthcare facilities to ensure antibiotics are used appropriately and only when necessary. This includes regular assessment of whether the medication remains clinically indicated and monitoring for both therapeutic effectiveness and adverse reactions.
The consultant pharmacist interviewed during the inspection emphasized that staff should have been "monitoring for signs and symptoms of UTI to ensure the antibiotic is working as a prophylaxis" and following up with physicians about the prolonged use to "reduce adverse effects and improve resident outcomes."
Confusion Among Staff About Medication Classification
The inspection revealed concerning gaps in staff knowledge about the medication they were administering. During interviews, the facility's Infection Preventionist incorrectly stated that methenamine hippurate "is not an antibiotic" and was instead "antibacterial," demonstrating confusion about the medication's classification and monitoring requirements.
This misunderstanding had direct implications for patient care. The Infection Preventionist told inspectors they "did not do any monitoring for signs and symptoms of UTI" because they viewed the medication as antibacterial rather than antibiotic, despite the facility's own antibiotic stewardship policies requiring such oversight.
The consultant pharmacist clarified that methenamine hippurate is indeed classified as an antibiotic and requires the same monitoring protocols as other antimicrobial agents. This discrepancy in understanding among key clinical staff highlighted systemic issues with medication management education and protocol implementation.